NDC 51991-897
Rivastigmine Transdermal System 4.6 mg per 24 h patch, extended release
On the label: Breckenridge Pharmaceutical, Inc..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Adhexpharma | Chenove, France | Makes it | Problems found, fixed voluntarilyJun 14, 2023 · 2 inspections |
Product details
- Generic drug
- Rivastigmine: every company that makes it
- Form
- patch, extended release, transdermal
- Strength
- 4.6 mg per 24 h
- Approval
- ANDA ANDA209063
- On the market since
- Dec 19, 2019
- Package NDCs
51991-897-3051991-897-99- Official label
- DailyMed (National Library of Medicine), updated Jan 15, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?